PHOREMOST Trademark

Trademark Overview

On Thursday, June 11, 2015, a trademark application was filed for PHOREMOST with the United States Patent and Trademark Office. The USPTO has given the PHOREMOST trademark a serial number of 86660020. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, June 14, 2023. This trademark is owned by PhoreMost Limited. The PHOREMOST trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research for medical purposes in the field of cancerous diseases; providing scientific and pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals for the alleviation, diagnosis, prevention and treatment of disease and medical conditions; research and development services in connection with finding and developing new pharmaceutical products for others to put on the market; providing research services in the field of cancer and cancer prevention; providing phenotypic screening, namely, screenings that feature technology that enables targeted screening for systematic identification and access to intracellular druggable sites for scientific and pharmaceutical research and drug discovery purposes; providing information, advisory and consultancy services in relation to the aforesaid services
phoremost

General Information

Serial Number86660020
Word MarkPHOREMOST
Filing DateThursday, June 11, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, June 14, 2023
Registration Number5153605
Registration DateTuesday, March 7, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2016

Trademark Statements

Pseudo MarkFOREMOST
Goods and ServicesScientific research for medical purposes in the field of cancerous diseases; providing scientific and pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals for the alleviation, diagnosis, prevention and treatment of disease and medical conditions; research and development services in connection with finding and developing new pharmaceutical products for others to put on the market; providing research services in the field of cancer and cancer prevention; providing phenotypic screening, namely, screenings that feature technology that enables targeted screening for systematic identification and access to intracellular druggable sites for scientific and pharmaceutical research and drug discovery purposes; providing information, advisory and consultancy services in relation to the aforesaid services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 16, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePhoreMost Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPampisford CB223FT
GB
Party NamePhoreMost Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCambridge CB23 8DS
GB
Party NamePhoreMost Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCambridge CB23 8DS
GB

Trademark Events

Event DateEvent Description
Wednesday, June 14, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, June 14, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 14, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, December 14, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, March 7, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, February 21, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 21, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 1, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 1, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 1, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 1, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 7, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, February 2, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, November 21, 2016NOTICE OF ALLOWANCE CANCELLED
Saturday, January 7, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 21, 2016TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, May 31, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 5, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 16, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 1, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 1, 2016ASSIGNED TO LIE
Tuesday, March 1, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 1, 2016EXAMINER'S AMENDMENT ENTERED
Monday, February 29, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 29, 2016EXAMINERS AMENDMENT E-MAILED
Monday, February 29, 2016EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 3, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 3, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 1, 2016ASSIGNED TO LIE
Thursday, January 21, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 21, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 21, 2015NON-FINAL ACTION E-MAILED
Monday, September 21, 2015NON-FINAL ACTION WRITTEN
Monday, September 21, 2015ASSIGNED TO EXAMINER
Wednesday, June 17, 2015NOTICE OF PSEUDO MARK E-MAILED
Tuesday, June 16, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 15, 2015NEW APPLICATION ENTERED

Related Keywords

phoremost research providing services scientific pharmaceutical field medical screening information cancer